Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

A group of tech executives, app developers and Silicon Valley philosophers is seeking to streamline the messy matters of the ...

Schroeder, who is 28 and lives in Fargo, North Dakota, texts Cole “all day, every day” on OpenAI’s app. In the morning, he ...

Today's AI agents are a primitive approximation of what agents are meant to be. True agentic AI requires serious advances in reinforcement learning and complex memory.